BiondVax Pharmaceuticals Ltd. Stock Company Profile
Information
Jerusalem BioPark Building, 2nd floor Hadassah Ein Kerem Campus
Jerusalem 7403618
972 8 930 2529
www.biondvax.com
Industry: Biotechnology
Sector: Healthcare
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
